Detalles de la búsqueda
1.
Phase I Pharmacokinetic Study of Niraparib in Chinese Patients with Epithelial Ovarian Cancer.
Oncologist
; 25(1): 19-e10, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31439812
2.
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
Cancer
; 119(24): 4290-8, 2013 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24122767
3.
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.
BMC Cancer
; 13: 242, 2013 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23679351
4.
Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study.
Lancet Oncol
; 12(4): 369-76, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21429799
5.
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
J Clin Oncol
; 23(13): 2918-25, 2005 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15860850
6.
Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer.
Mol Cancer Ther
; 14(11): 2634-41, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26330547
7.
Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications.
Clin Lung Cancer
; 6(3): 170-4, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15555218
8.
Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.
PLoS One
; 9(10): e108048, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25314641
9.
Motesanib plus carboplatin/paclitaxel in patients with advanced squamous non-small-cell lung cancer: results from the randomized controlled MONET1 study.
J Thorac Oncol
; 9(8): 1154-61, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25157768
10.
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer.
J Thorac Oncol
; 8(3): 329-37, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23370314
11.
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study.
Eur J Cancer
; 48(4): 547-63, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22240283
12.
International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1.
J Clin Oncol
; 30(23): 2829-36, 2012 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22753922
13.
Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program.
Clin Epidemiol
; 3: 139-48, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21607015
14.
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.
J Clin Oncol
; 29(33): 4442-51, 2011 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22010015
15.
IV Bisphosphonate therapy: making the case for calcium and vitamin D supplementation.
Med Hypotheses
; 64(4): 879-80, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15694711
16.
Biomarkers as predictors of response to treatment with motesanib in patients with progressive advanced thyroid cancer.
J Clin Endocrinol Metab
; 95(11): 5018-27, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20739388
17.
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
J Natl Cancer Inst
; 97(1): 59-69, 2005 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15632381
18.
Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis.
J Rheumatol
; 30(2): 355-63, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12563696
Resultados
1 -
18
de 18
1
Próxima >
>>